Ajanta Pharma share news, announcements and annual reports
NSE: AJANTPHARMBSE: 532331Pharmaceuticals & BiotechnologyMid Cap
Ajanta Pharma Limited · Face value ₹2 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed May 2000 on NSE, Jun 2000 on BSE
Last close ₹3,353.60down ₹27.40 (0.81%)BSE ₹3,348.60
Share price at the NSE close on 27 Oct 2026. Previous close ₹3,381.00.
27 Oct: open ₹3,385.00, high ₹3,529.30, low ₹3,330.00
52-week range of traded prices to 27 Oct 2026
₹2,382.00Low, 28 Oct 2025₹3,796.00High, 18 Aug 2026
- Next results date: the board meets on 30 Oct 2026 to consider: financial results. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹41,906 Cr236th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 36.93
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 9.26
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 1.79%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 27.3%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 27.2%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.05
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 1,74,37450.1% delivered
Ajanta Pharma orders, deals and press releases
78 filed, newest first. Page 1 of 2.
Dec 2025
23 Dec · Business
Mar 2025
20 Mar · Business
Aug 2023
Oct 2022
Sep 2021
Oct 2020
Apr 2020
Sep 2018
Aug 2018
Nov 2017
Sep 2017
Aug 2017
Jul 2017
Mar 2017
Jan 2017
Nov 2016
Sep 2016
Jul 2016
Jun 2016
May 2016
Apr 2016
Mar 2016
Feb 2016
Dec 2015
Nov 2015
Oct 2015
Aug 2015
May 2015
Jan 2015
Oct 2014
Aug 2014
May 2014
5 May · Business
Compensation Committee of Directors at its meeting held on May 05, 2014, has allotted 17,800 fully paid up equity shares of Rs. 5/- each and 8,900 bonus shares thereon in the ratio of 1:2. These shares have been allotted upon exercise of options granted to the employees under Employees Stock Option Scheme 2011 of the Company.In view of the above, the issued and paid up capital of the Company shall be increased to Rs. 17,58,87,000 consisting 3,51,77,400 equity shares of Rs. 5/- each.
Jan 2014
Oct 2013
Sep 2013
19 Sep · Business
Executive Committee of the Board of Directors at its meeting held on September 19, 2013 has allotted 1,17,16,900 fully paid up equity shares of Rs. 5/- each. These shares have been allotted as a part of bonus issue. The ratio of bonus was 1:2 i.e. One (1) new fully paid up share of Rs. 5/- each for every Two (2) shares held. The said shares will rank pari-passu with the existing shares of the Company in all respects. In view of above the paid up capital of the company shall be increased to Rs. 17,57,53,500 consisting of 3,51,50,700 equity shares of Rs. 5/- each.